Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
NVS US​

Novartis Ag Sponsored ADR(NVS US)

$151.12-5.153.30%Ext:$157.00+5.883.89%(Market Closed · 00:00:04 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

SEC Filings by Owner

Insider Ownership

NOVARTIS AG(134)

  • 3OWNERSHIP DOCUMENT28 Oct 2025
  • 3OWNERSHIP DOCUMENT27 Jun 2022
  • 3Initial statement of beneficial ownership14 Aug 2020
  • 4Statement of changes in beneficial ownership16 Jul 2020
  • 3Initial statement of beneficial ownership13 Jul 2020
  • 4Statement of changes in beneficial ownership2 Jul 2020
  • 3Initial statement of beneficial ownership25 Jun 2020
  • 4PRIMARY DOCUMENT22 Jun 2020
  • 3Initial statement of beneficial ownership18 Jun 2020
  • 4PRIMARY DOCUMENT17 Jun 2020

Novartis Bioventures Ltd(85)

  • 4Statement of changes in beneficial ownership2 Jul 2020
  • 3Initial statement of beneficial ownership25 Jun 2020
  • 4PRIMARY DOCUMENT22 Jun 2020
  • 3Initial statement of beneficial ownership18 Jun 2020
  • 4PRIMARY DOCUMENT17 Jun 2020
  • 4PRIMARY DOCUMENT12 Jun 2020
  • 4PRIMARY DOCUMENT9 Jun 2020
  • 4PRIMARY DOCUMENT4 Jun 2020
  • 4Statement of changes in beneficial ownership12 Nov 2019
  • 3Initial statement of beneficial ownership6 Nov 2019

NOVARTIS PHARMA AG(33)

  • 3OWNERSHIP DOCUMENT27 Jun 2022
  • 3Initial statement of beneficial ownership14 Aug 2020
  • 4Statement of changes in beneficial ownership16 Jul 2020
  • 3Initial statement of beneficial ownership13 Jul 2020
  • 4Statement of changes in beneficial ownership12 Aug 2014
  • 4Statement of changes in beneficial ownership24 Sep 2012
  • 4Statement of changes in beneficial ownership23 Feb 2012
  • 4Statement of changes in beneficial ownership22 Nov 2011
  • 4/AStatement of changes in beneficial ownership (amendment)9 Dec 2011
  • 4Statement of changes in beneficial ownership13 Apr 2011

Novartis Institutes For BioMedical Research, Inc.(10)

  • 5PRIMARY DOCUMENT14 Feb 2019
  • 4Statement of changes in beneficial ownership23 Apr 2018
  • 3Initial statement of beneficial ownership18 Apr 2018
  • 4Statement of changes in beneficial ownership4 Apr 2018
  • 3Initial statement of beneficial ownership27 Mar 2018
  • 3Initial statement of beneficial ownership23 Mar 2018
  • 4Statement of changes in beneficial ownership14 Dec 2017
  • 4Statement of changes in beneficial ownership7 Mar 2017
  • 4Statement of changes in beneficial ownership11 May 2016
  • 3Initial statement of beneficial ownership5 May 2016

NOVARTIS CORP(2)

  • 4Statement of changes in beneficial ownership12 Dec 2005
  • 3/AInitial statement of beneficial ownership (amendment)8 Mar 2005

≥5% Ownership

NOVARTIS AG(50)

  • SC 13D/AMorphoSys AG17 Oct 2024
  • SC 13D/AMorphoSys AG15 Aug 2024
  • SC 13D/AMorphoSys AG21 Jun 2024
  • SC 13D/AMorphoSys AG17 Jun 2024
  • SC 13D/AMorphoSys AG10 Jun 2024
  • SC 13D/AMorphoSys AG28 May 2024
  • SC 13DMorphoSys AG18 Apr 2024
  • SC 13G/AXOMA Corp19 Aug 2020
  • SC 13GresTORbio, Inc.14 Feb 2018
  • SC 13DAdvanced Accelerator Applications S.A.1 Feb 2018

BlackRock Inc.(3)

  • SC 13G/ANovartis Ag2 Feb 2024
  • SC 13G/ANovartis Ag1 Feb 2023
  • SC 13GNovartis Ag4 Feb 2022

UBS AM, A Distinct Business Unit Of UBS ASSET MANAGEMENT AMERICAS LLC(1)

  • SC 13GNovartis Ag17 Jul 2025

Financials & Metrics

FinancialsChartingShort InterestEmployees